Clinical trial

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

NCT03794388

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Capsaicin Normalized identity: capsaicinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pregabalin Normalized identity: pregabalinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-03-19

PhasePHASE3

Conditions

Breast Cancer Patientunresolved

Interventions

CapsaicinDRUG · verified · RxNorm: capsaicin

PregabalinDRUG · verified · RxNorm: pregabalin

Sponsors & collaborators

Institut Cancerologie de l'Ouestlead sponsor

Grünenthal GmbHcollaborator

Mapped research locations

LilleFrance2 ToulouseFrance1 LyonFrance1 NiceFrance1 GrenobleFrance1 AngersFrance1 ReimsFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03794388 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.